Drug
Omeprazole And Sodium Bicarbonate
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | End Stage Renal Disease | 212 | 87.7 | 94.8 | signal |
| 2 | Chronic Kidney Disease | 788 | 78.2 | 108.7 | signal |
| 3 | Renal Injury | 195 | 49.2 | 52.9 | signal |
| 4 | Tubulointerstitial Nephritis | 101 | 40.8 | 42.3 | signal |
| 5 | Nephropathy | 50 | 40.3 | 41.1 | signal |
| 6 | Renal Failure | 431 | 24.3 | 28.6 | signal |
| 7 | Acute Kidney Injury | 456 | 22.6 | 26.9 | signal |
| 8 | Incorrect Product Administration Duration | 40 | 14.9 | 15.1 | signal |
| 9 | Vitamin D Deficiency | 19 | 14.7 | 14.8 | signal |
| 10 | Gastrooesophageal Reflux Disease | 155 | 14.6 | 15.4 | signal |
| 11 | Nocturia | 20 | 12.5 | 12.5 | signal |
| 12 | Renal Tubular Necrosis | 16 | 12.3 | 12.3 | signal |
| 13 | Dialysis | 20 | 10.6 | 10.7 | signal |
| 14 | Gallbladder Disorder | 21 | 8.8 | 8.9 | signal |
| 15 | Intervertebral Disc Degeneration | 10 | 8.1 | 8.1 | signal |
| 16 | Rebound Effect | 12 | 8.0 | 8.0 | signal |
| 17 | Hiatus Hernia | 13 | 7.6 | 7.6 | signal |
| 18 | Economic Problem | 15 | 7.3 | 7.4 | signal |
| 19 | Cholecystectomy | 11 | 7.3 | 7.3 | signal |
| 20 | Osteoporosis | 37 | 6.8 | 6.8 | signal |
| 21 | Micturition Urgency | 10 | 6.6 | 6.7 | signal |
| 22 | Hyperlipidaemia | 10 | 6.3 | 6.3 | signal |
| 23 | Multiple Fractures | 13 | 5.9 | 5.9 | signal |
| 24 | Nephrolithiasis | 33 | 5.4 | 5.5 | signal |
| 25 | Restless Legs Syndrome | 13 | 5.4 | 5.4 | signal |
| 26 | Bone Disorder | 13 | 5.3 | 5.4 | signal |
| 27 | Renal Impairment | 59 | 5.3 | 5.4 | signal |
| 28 | Cholecystitis | 8 | 5.1 | 5.1 | signal |
| 29 | Renal Pain | 7 | 5.0 | 5.0 | signal |
| 30 | Incontinence | 7 | 5.0 | 5.0 | signal |
| 31 | Osteopenia | 10 | 4.9 | 5.0 | signal |
| 32 | Hypomagnesaemia | 9 | 4.9 | 4.9 | signal |
| 33 | Proteinuria | 12 | 4.8 | 4.8 | signal |
| 34 | Sleep Apnoea Syndrome | 12 | 4.7 | 4.7 | signal |
| 35 | Impaired Gastric Emptying | 8 | 4.7 | 4.7 | signal |
| 36 | Product Prescribing Issue | 12 | 4.4 | 4.5 | signal |
| 37 | Renal Disorder | 27 | 4.4 | 4.4 | signal |
| 38 | Gastritis | 15 | 4.3 | 4.3 | signal |
| 39 | Kidney Infection | 11 | 4.2 | 4.2 | signal |
| 40 | Gout | 10 | 4.2 | 4.2 | signal |
| 41 | Pollakiuria | 23 | 4.2 | 4.2 | signal |
| 42 | Cholelithiasis | 18 | 4.1 | 4.2 | signal |
| 43 | Oesophagitis | 6 | 4.1 | 4.1 | signal |
| 44 | Infusion Site Pain | 7 | 4.1 | 4.1 | signal |
| 45 | Intervertebral Disc Protrusion | 12 | 4.1 | 4.1 | signal |
| 46 | Rotator Cuff Syndrome | 7 | 4.1 | 4.1 | signal |
| 47 | Nerve Injury | 6 | 4.1 | 4.1 | signal |
| 48 | Injury | 38 | 4.1 | 4.1 | signal |
| 49 | Foot Fracture | 10 | 4.0 | 4.0 | signal |
| 50 | Haematuria | 18 | 4.0 | 4.0 | signal |
| 51 | Feeling Jittery | 10 | 3.9 | 4.0 | signal |
| 52 | Coronary Artery Occlusion | 7 | 3.8 | 3.8 | signal |
| 53 | Ligament Sprain | 5 | 3.8 | 3.8 | signal |
| 54 | Urinary Incontinence | 15 | 3.8 | 3.8 | signal |
| 55 | Carpal Tunnel Syndrome | 7 | 3.8 | 3.8 | signal |
| 56 | Activities Of Daily Living Impaired | 10 | 3.8 | 3.8 | signal |
| 57 | Back Disorder | 8 | 3.7 | 3.7 | signal |
| 58 | Chronic Obstructive Pulmonary Disease | 25 | 3.6 | 3.6 | signal |
| 59 | Gastrointestinal Pain | 5 | 3.4 | 3.4 | signal |
| 60 | Tardive Dyskinesia | 13 | 3.4 | 3.4 | signal |
| 61 | Eye Infection | 5 | 3.4 | 3.4 | signal |
| 62 | Oral Discomfort | 6 | 3.2 | 3.3 | signal |
| 63 | Gastric Disorder | 15 | 3.2 | 3.3 | signal |
| 64 | Drug Effect Less Than Expected | 6 | 3.2 | 3.2 | signal |
| 65 | Eructation | 8 | 3.2 | 3.2 | signal |
| 66 | Hospice Care | 4 | 3.1 | 3.1 | no signal |
| 67 | Extrapyramidal Disorder | 10 | 3.0 | 3.0 | signal |
| 68 | Poor Quality Product Administered | 4 | 2.9 | 3.0 | no signal |
| 69 | Pharyngeal Oedema | 6 | 2.9 | 2.9 | signal |
| 70 | Breast Pain | 4 | 2.8 | 2.8 | no signal |
| 71 | Hunger | 5 | 2.8 | 2.8 | signal |
| 72 | Product Taste Abnormal | 5 | 2.8 | 2.8 | signal |
| 73 | Pruritus Generalised | 8 | 2.7 | 2.8 | signal |
| 74 | Glossodynia | 8 | 2.7 | 2.7 | signal |
| 75 | Product Availability Issue | 8 | 2.7 | 2.7 | signal |
| 76 | Emotional Disorder | 11 | 2.7 | 2.7 | signal |
| 77 | Gastric Cancer | 9 | 2.6 | 2.7 | signal |
| 78 | Internal Haemorrhage | 4 | 2.6 | 2.6 | no signal |
| 79 | Local Swelling | 6 | 2.6 | 2.6 | signal |
| 80 | Spinal Operation | 4 | 2.5 | 2.5 | no signal |
| 81 | No Therapeutic Response | 4 | 2.4 | 2.4 | no signal |
| 82 | Deformity | 3 | 2.4 | 2.4 | no signal |
| 83 | Increased Appetite | 6 | 2.4 | 2.4 | no signal |
| 84 | Complication Associated With Device | 4 | 2.3 | 2.3 | no signal |
| 85 | Central Nervous System Lesion | 4 | 2.2 | 2.2 | no signal |
| 86 | Product Odour Abnormal | 3 | 2.2 | 2.2 | no signal |
| 87 | Knee Arthroplasty | 6 | 2.2 | 2.2 | no signal |
| 88 | Abasia | 7 | 2.1 | 2.1 | no signal |
| 89 | Pelvic Pain | 5 | 2.1 | 2.1 | no signal |
| 90 | Serotonin Syndrome | 5 | 2.0 | 2.0 | no signal |
| 91 | Product Substitution Issue | 15 | 2.0 | 2.0 | no signal |
| 92 | Drug Effect Decreased | 14 | 1.9 | 1.9 | no signal |
| 93 | Injection Site Extravasation | 3 | 1.8 | 1.8 | no signal |
| 94 | Intentional Drug Misuse | 5 | 1.8 | 1.8 | no signal |
| 95 | Anorexia | 3 | 1.7 | 1.7 | no signal |
| 96 | Akathisia | 3 | 1.7 | 1.7 | no signal |
| 97 | Wrong Technique In Drug Usage Process | 8 | 1.6 | 1.6 | no signal |
| 98 | Incorrect Drug Administration Duration | 6 | 1.6 | 1.6 | no signal |
| 99 | Product Storage Error | 18 | 1.6 | 1.6 | no signal |
| 100 | Emotional Distress | 25 | 1.5 | 1.6 | no signal |
| 101 | Dystonia | 4 | 1.5 | 1.5 | no signal |
| 102 | Inappropriate Schedule Of Drug Administration | 14 | 1.5 | 1.5 | no signal |
| 103 | Bone Density Decreased | 6 | 1.4 | 1.4 | no signal |
| 104 | Application Site Pruritus | 4 | 1.3 | 1.3 | no signal |
| 105 | Drug Dose Omission | 28 | 1.3 | 1.3 | no signal |
| 106 | Injection Site Urticaria | 4 | 1.2 | 1.2 | no signal |
| 107 | Application Site Erythema | 4 | 1.1 | 1.1 | no signal |
| 108 | Extra Dose Administered | 6 | 1.1 | 1.1 | no signal |
| 109 | Multiple Sclerosis Relapse | 10 | 1.1 | 1.1 | no signal |
| 110 | Device Issue | 11 | 0.9 | 0.9 | no signal |
| 111 | Renal Cancer | 6 | 0.9 | 0.9 | no signal |
| 112 | Dermatitis Atopic | 6 | 0.9 | 0.9 | no signal |
| 113 | Injection Site Haemorrhage | 9 | 0.9 | 0.9 | no signal |
| 114 | Product Adhesion Issue | 4 | 0.8 | 0.8 | no signal |
| 115 | Device Leakage | 4 | 0.7 | 0.7 | no signal |
| 116 | Device Difficult To Use | 3 | 0.3 | 0.3 | no signal |